NewAmsterdam Pharma Co N.V. (NAMS) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$203.82M | +15.6% |
| 2024 | -$241.60M | -36.5% |
| 2023 | -$176.94M | -681.7% |
| 2022 | -$22.63M | +45.8% |
| 2021 | -$41.78M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$203.82M | +15.6% |
| 2024 | -$241.60M | -36.5% |
| 2023 | -$176.94M | -681.7% |
| 2022 | -$22.63M | +45.8% |
| 2021 | -$41.78M | — |